47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | -0,1 | -0,8 | -609,4 |
EBITDA | 1,3 | 0,9 | -0 | -104 |
Short time liabilities | 18,8 | 21,7 | 25,7 | 18,1 |
Equity capital | -6,1 | -6,2 | -7,1 | -13,9 |
Operating profit (EBIT) | 0,8 | 0,3 | -0,5 | -276,2 |
Assets | 14,6 | 17 | 19,8 | 16,8 |
Net profit (loss) | 0,5 | -0,1 | -0,9 | -587 |
Cash | 0,6 | 1,2 | 1 | -15,8 |
Net income from sale | 62,7 | 77,7 | 88,9 | 14,3 |
Liabilities and provisions for liabilities | 20,7 | 23,2 | 26,9 | 16 |
Working assets | 10,6 | 13,4 | 16,6 | 23,9 |
Depreciation | 0,5 | 0,6 | 0,5 | -26,3 |
% | % | % | p.p. | |
Profitability of capital | -8,8 | 2 | 12,2 | 10,2 |
Equity capital to total assets | -41,6 | -36,6 | -35,7 | 0,9 |
Gross profit margin | 0,8 | -0,1 | -0,9 | -0,8 |
EBITDA Margin | 2,1 | 1,2 | -0 | -1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 109 | 102 | 105 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane